Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis.
The pharmacokinetics of teicoplanin were determined after multiple 30-min intravenous infusions of 10 to 15 mg/kg every 12 to 24 h in 11 intravenous drug abuse (IVDA) patients being treated for bacterial endocarditis. Multiple serum samples were obtained over 7 to 14 days. Twenty-four-hour urine col...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1991
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245081/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1829880/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.4.696 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
